Interpersonal problemsBPDSI‐IV1‐interpersonal relationships · patients with borderline personality disorder
1 finding from 1 review
Avoidance of abandonment BPDSI‐IV1‐abandonment · patients with borderline personality disorder
1 finding from 1 review
Identity disturbance BPDSI‐IV1‐identity disturbance · patients with borderline personality disorder
1 finding from 1 review
Dissociation/paranoid ideation BPDSI‐IV1‐paranoid ideation · patients with borderline personality disorder
1 finding from 1 review
Intervention not reported
Any neurological sequelae other than hearing loss defined as health consequences of the infection that involve the central nervous system during the · children with acute bacterial meningitis
The intervention showed no clear difference in any neurological sequelae other than hearing loss defined as health… (low certainty).
1 finding from 1 review
Intervention not reported
Short‐term neurological sequelae other than hearing loss defined as sequelae present up to 6 weeks after hospital discharge · children with acute bacterial meningitis
The intervention may leads to higher short‐term neurological sequelae other than hearing loss defined as… (low certainty).
1 finding from 1 review
Intervention not reported
Long‐term neurological sequelae other than hearing loss defined as sequelae present between 6 weeks after hospital discharge and the last time point reported in the study · children with acute bacterial meningitis
The intervention may leads to higher long‐term neurological sequelae other than hearing loss defined as… (low certainty).
1 finding from 1 review
Pain (mean score, split-mouth) · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
It is very uncertain whether topical triamcinolone acetonide changes pain (mean score, split-mouth) compared with cryotherapy (very low certainty).
1 finding from 1 review
Adverse events (split-mouth) · People with symptomatic, biopsy-confirmed oral lichen planus (OLP); not concurrently receiving other OLP treatment
Topical triamcinolone acetonide led to lower adverse events (split-mouth) compared with cryotherapy; GRADE not reported.
1 finding from 1 review
Relapse · patients with schizophrenia
CBT showed no clear difference in global state: relapse compared with ALL OTHER PSYCHOLOGICAL THERAPIES (low certainty).
1 finding from 1 review
Patient readmissions · patients with schizophrenia
CBT showed no clear difference in global state: rehospitalisation* compared with ALL OTHER PSYCHOLOGICAL THERAPIES (low certainty).
1 finding from 1 review
Mental state: General ‐ clinically important change (no improvement) · patients with schizophrenia
CBT showed no clear difference in mental state: General ‐ clinically important change (no improvement) compared with ALL OTHER PSYCHOLOGICAL THERAPIES (low certainty).
1 finding from 1 review
Adverse effect/event: death ‐ any cause · patients with schizophrenia
CBT showed no clear difference in adverse effect/event: death ‐ any cause compared with ALL OTHER PSYCHOLOGICAL THERAPIES (low certainty).
1 finding from 1 review
Social functioning · patients with schizophrenia
1 finding from 1 review
QoL · patients with schizophrenia
1 finding from 1 review
Satisfaction with treatment: leaving the study early Endpoint data (events) · patients with schizophrenia
CBT may leads to lower satisfaction with treatment ‐ leaving the study early for any reason compared with ALL OTHER PSYCHOLOGICAL THERAPIES (low certainty).
1 finding from 1 review
PTSD diagnosis · children and adolescents exposed to traumatic events;
It is very uncertain whether CBT changes PTSD diagnosis compared with other psychological therapies (very low certainty).
1 finding from 1 review
PTSD total symptoms · children and adolescents exposed to traumatic events;
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
It is very uncertain whether EMDR changes leaving study early for any reason compared with other therapies (very low certainty).
1 finding from 1 review
Severity of PTSD symptoms ‐ Clinician‐rated · Adults with PTSD for at least 3 months
1 finding from 1 review